Teva receives FDA approval for acne medication

JERUSALEM The Food and Drug Administration has approved a generic version of an acne medication.

Teva Pharmaceutical Industries announced that the FDA had approved its version of Medicis Pharmaceutical Corp.’s Solodyn (minocycline hydrochloride) extended-release tablets in the 45 mg, 90 mg and 135 mg strengths and that it has begun shipping the drug.

The drug is used to treat acne. Sales of Solodyn were $365 million for the 12 months ending Jan. 31, according to IMS Health data.

Teva said it is in patent litigation for the drug in the United States District Court for the District of Delaware, but a trial date has not been set.